Canadian Pharmaceuticals & Biotech High Growth Potential Companies

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada.

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China.

Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide.

Harvest Health & Recreation Inc. cultivates, processes, sells, and retails cannabis in the United States.

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells various cannabis consumer packaged goods for medical and adult use in the United States.

Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States.

Ayr Strategies Inc. is a vertically-integrated multi-state operator in cannabis sector in the United States.

Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent protected pharmaceuticals in Canada, Europe, the United States, and internationally.

Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally.

Columbia Care Inc. produces and sells cannabis in the United States and the European Union.

Heritage Cannabis Holdings Corp., through its subsidiaries, focuses on becoming a vertically integrated cannabis provider in Canada.

Theratechnologies Inc., a biopharmaceutical company, markets prescription products in the United States, Europe, and Canada.

Charlotte's Web Holdings, Inc. produces and distributes hemp-based cannabidiol wellness products in the United States.

Rubicon Organics Inc. produces and sells cannabis in Canada.

Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally.